Financial markets
Klotho Neurosciences Regains Compliance with NASDAQ Listing Requirements
Klotho Neurosciences, a gene and cell therapy company, has regained compliance with the minimum bid price and stockholders' equity threshold set by NASDAQ. The company's shares will remain listed and traded on the NASDAQ Stock Market after meeting the requirements. Klotho Neurosciences focuses on developing innovative cell